Nurix Therapeutics Inc
NASDAQ:NRIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nurix Therapeutics Inc
NASDAQ:NRIX
|
US |
|
Fate Therapeutics Inc
NASDAQ:FATE
|
US |
|
M
|
Marcventures Holdings Inc
XPHS:MARC
|
PH |
|
Blue Moon Metals Inc
XTSX:MOON
|
CA |
|
A
|
Asia Grocery Distribution Ltd
HKEX:8413
|
HK |
|
L
|
Levinstein Properties Ltd
TASE:LVPR
|
IL |
|
P
|
Pruksa Holding PCL
SET:PSH
|
TH |
|
Nucleus Software Exports Ltd
NSE:NUCLEUS
|
IN |
|
Mugen Estate Co Ltd
TSE:3299
|
JP |
|
Mphasis Ltd
NSE:MPHASIS
|
IN |
|
Digital Brands Group Inc
NASDAQ:DBGI
|
US |
|
C
|
Cleen Energy AG
VSE:CLEN
|
AT |
|
W
|
Winpak Ltd
TSX:WPK
|
CA |
|
Mewah International Inc
SGX:MV4
|
SG |
Wall Street
Price Targets
NRIX Price Targets Summary
Nurix Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
NRIX
is 30.6 USD
with a low forecast of 22.22 USD and a high forecast of 43.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NRIX's stock price target?
Price Target
30.6
USD
According to Wall Street analysts, the average 1-year price target for
NRIX
is 30.6 USD
with a low forecast of 22.22 USD and a high forecast of 43.05 USD.
What is Nurix Therapeutics Inc's Revenue forecast?
Projected CAGR
19%
For the last 6 years the
compound annual growth rate for
Nurix Therapeutics Inc's revenue is
18%.
The projected
CAGR
for the next 3 years is
19%.
